The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Lebedev I.S.

Pirogov Russian National Research Medical University

Gilyarov M.Yu.

Pirogov Russian National Research Medical University;
Pirogov Moscow City Clinical Hospital No. 1

Efremova O.I.

Pirogov Russian National Research Medical University

Zolotukhin I.A.

Pirogov Russian National Research Medical University

Kirienko A.I.

Pirogov Russian National Research Medical University

Response to Comment to the Article “Does the Use of Prognostic Scales and Clinical Guidelines Always Guarantee the Survival of Patients with Massive Pulmonary Embolism”

Authors:

Lebedev I.S., Gilyarov M.Yu., Efremova O.I., Zolotukhin I.A., Kirienko A.I.

More about the authors

Journal: Journal of Venous Disorders. 2023;17(1): 45‑47

DOI: 10.17116/flebo20231701145

Read: 822 times

Download PDF (RU)
Contact the author
Table of contents

RESPONSE TO COMMENT TO THE ARTICLE “DOES THE USE OF PROGNOSTIC SCALES AND CLINICAL GUIDELINES ALWAYS GUARANTEE THE SURVIVAL OF PATIENTS WITH MASSIVE PULMONARY EMBOLISM”
RESPONSE TO COMMENT TO THE ARTICLE “DOES THE USE OF PROGNOSTIC SCALES AND CLINICAL GUIDELINES ALWAYS GUARANTEE THE SURVIVAL OF PATIENTS WITH MASSIVE PULMONARY EMBOLISM”

To cite this article:

Lebedev IS, Gilyarov MYu, Efremova OI, Zolotukhin IA, Kirienko AI. Response to Comment to the Article “Does the Use of Prognostic Scales and Clinical Guidelines Always Guarantee the Survival of Patients with Massive Pulmonary Embolism”. Journal of Venous Disorders. 2023;17(1):45‑47. (In Russ.)
https://doi.org/10.17116/flebo20231701145

Подписка 2026 Флебология (Journal of Venous Disorders)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Response to Comment to the Article “Does the Use of Prognostic Scales and Clinical Guidelines Always Guarantee the Survival of Patients with Massive Pulmonary Embolism”.

Authors:

Lebedev I.S.

Pirogov Russian National Research Medical University

Gilyarov M.Yu.

Pirogov Russian National Research Medical University;
Pirogov Moscow City Clinical Hospital No. 1

Efremova O.I.

Pirogov Russian National Research Medical University

Zolotukhin I.A.

Pirogov Russian National Research Medical University

Kirienko A.I.

Pirogov Russian National Research Medical University

Received:

11.09.2022

Accepted:

12.09.2022

Close metadata

References:

  1. Sebaaly J, Covert K. Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations. Ann Pharmacother. 2018;52(9):898-909.  https://doi.org/10.1177/1060028018768449
  2. Deal EN, Hollands JM, Riney JN, Skrupky LP, Smith JR, Reichley RM. Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series. J Thromb Thrombolysis. 2011;32(2):188-194.  https://doi.org/10.1007/s11239-011-0584-7
  3. Lalama JT, Feeney ME, Vandiver JW, Beavers KD, Walter LN, McClintic JR. Assessing an enoxaparin dosing protocol in morbidly obese patients. J Thromb Thrombolysis. 2015;39(4):516-521.  https://doi.org/10.1007/s11239-014-1117-y
  4. Anderson MR, Shashaty MGS. Impact of Obesity in Critical Illness. Chest. 2021;160(6):2135-2145. https://doi.org/10.1016/j.chest.2021.08.001
  5. Hanni CM, Wilhelm SM, Korkis B, Petrovitch EA, Tsilimingras KV, McConachie SM. Therapeutic Enoxaparin in the Morbidly Obese Patient: A Case Report and Review of the Literature. Hosp Pharm. 2019;54(6):371-377.  https://doi.org/10.1177/0018578718802839
  6. Gibson CM, Hall C, Davis S, Schillig JM. Comparison of two escalated enoxaparin dosing regimens for venous thromboembolism prophylaxis in obese hospitalized patients. J Thromb Thrombolysis. 2021;52(2):577-583.  https://doi.org/10.1007/s11239-020-02360-9
  7. Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management. Vasc Med. 2020;25(2):160-173.  https://doi.org/10.1177/1358863X19898253
  8. Chen Y, Wang J, Shi ZJ, Zhang Y, Yang Q, Xu Y. Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study. Clin Appl Thromb Hemost. 2021;27:10760296211042938. https://doi.org/10.1177/10760296211042938
  9. ten Berg MJ, van den Bemt PM, Huisman A, Schobben AF, Egberts TC, van Solinge WW. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. Ann Pharmacother. 2009;43(9):1405-1412. https://doi.org/10.1345/aph.1L646
  10. Bloom MB, Zaw AA, Hoang DM, Mason R, Alban RF, Chung R, Melo N, Volod O, Ley EJ, Margulies DR. Body mass index strongly impacts the diagnosis and incidence of heparin-induced thrombocytopenia in the surgical intensive care unit. J Trauma Acute Care Surg. 2016;80(3):398-403; discussion 403-404.  https://doi.org/10.1097/TA.0000000000000952
  11. Kaur J, Arsene C, Yadav SK, Ogundipe O, Malik A, Sule AA, Krishnamoorthy G. Risk Factors in Hospitalized Patients for Heparin-Induced Thrombocytopenia by Real World Database: A New Role for Primary Hypercoagulable States. J Hematol. 2020;10(4):171-177.  https://doi.org/10.14740/jh876
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.